Hedge Fund - Propel Bio Management
Tscan Therapeutics Inc. (TCRX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $0 | 0% | 0 | $1.45 |
| 2 | 2025 - Q3 (2025-09-30) | $3,516,793 | 3.52% | 1,932,304 | $1.77 |
| 3 | 2025 - Q2 (2025-06-30) | $3,026,352 | 3.67% | 2,087,139 | $1.44 |
| 4 | 2025 - Q1 (2025-03-31) | $2,880,252 | 3.35% | 2,087,139 | $2.16 |
| 5 | 2024 - Q4 (2024-12-31) | $6,344,903 | 6.3% | 2,087,139 | $4.53 |
| 6 | 2024 - Q3 (2024-09-30) | $10,393,952 | 6.02% | 2,087,139 | $6.03 |
| 7 | 2024 - Q2 (2024-06-30) | $12,209,763 | 7.91% | 2,087,139 | $7.88 |
| 8 | 2024 - Q1 (2024-03-31) | $16,571,884 | 9.64% | 2,087,139 | $6.29 |
| 9 | 2023 - Q4 (2023-12-31) | $12,168,020 | 10.08% | 2,087,139 | $4.58 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center